|
|
|
|
|
Bortezomib |
|
Bortezomib |
|
179324-69-7 |
|
Antineoplastics.
|
|
Appearance: White or off-white crystalline powder Identification: (by NMR) The Nuclear Magnetic Resonance spectrum of the sample should be the same as that of reference material Loss on drying: ¡Â0.5% Burned ash: ¡Â0.1% Heavy Metals: ¡Â20ppm Assay(HPLC): ¡Ã98.5% |
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|